For research use only. Not for therapeutic Use.
Etidocaine (hydrochloride) is a long aminoamide local anesthetic[1].
IGL-EDC formulations can induce a significant increase in human fibroblasts survival[1].
Etidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit[2].
| Catalog Number | I006449 |
| CAS Number | 36637-19-1 |
| Synonyms | N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide;hydrochloride |
| Molecular Formula | C17H29ClN2O |
| Purity | ≥95% |
| InChI | InChI=1S/C17H28N2O.ClH/c1-6-12-19(8-3)15(7-2)17(20)18-16-13(4)10-9-11-14(16)5;/h9-11,15H,6-8,12H2,1-5H3,(H,18,20);1H |
| InChIKey | LMWQQUMMGGIGJQ-UHFFFAOYSA-N |
| SMILES | CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C.Cl |
| Reference | [1]. Oliveira, et al. Sustained Release from Ionic-Gradient Liposomes Significantly Decreases ETIDOCAINE Cytotoxicity. Pharmaceutical research vol. 35, 12 229. 10 Oct. 2018. [2]. Langerman, L, et al. The partition coefficient as a predictor of local anesthetic potency for spinal anesthesia: evaluation of five local anesthetics in a mouse model. Anesthesia and analgesia vol. 79,3 (1994): 490-4. |
